Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
Status:
Completed
Trial end date:
2012-10-05
Target enrollment:
Participant gender:
Summary
This was a real-world, prospective, open-label, multicenter study in which participants were
randomized (1:1) to receive intravenous (IV) vancomycin or IV daptomycin. The purpose of this
study is to compare infection-related hospital length of stay, along with a number of
participant-reported outcomes, between participants with complicated skin and soft tissue
infection treated with daptomycin and vancomycin.